RHKJ.F Stock Overview
Offers in-patient, semi-patient, and outpatient healthcare services in Germany. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
RHÖN-KLINIKUM Aktiengesellschaft Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €13.25 |
52 Week High | €13.85 |
52 Week Low | €11.15 |
Beta | -0.11 |
11 Month Change | -4.33% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | -37.20% |
Change since IPO | -77.75% |
Recent News & Updates
Recent updates
Shareholder Returns
RHKJ.F | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 3.3% | 2.2% |
1Y | n/a | 4.9% | 32.6% |
Return vs Industry: Insufficient data to determine how RHKJ.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how RHKJ.F performed against the US Market.
Price Volatility
RHKJ.F volatility | |
---|---|
RHKJ.F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RHKJ.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine RHKJ.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1973 | 18,507 | Tobias Kaltenbach | www.rhoen-klinikum-ag.com |
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary
RHKJ.F fundamental statistics | |
---|---|
Market cap | US$876.71m |
Earnings (TTM) | US$47.01m |
Revenue (TTM) | US$1.92b |
18.6x
P/E Ratio0.5x
P/S RatioIs RHKJ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RHKJ.F income statement (TTM) | |
---|---|
Revenue | €1.84b |
Cost of Revenue | €1.62b |
Gross Profit | €211.75m |
Other Expenses | €166.88m |
Earnings | €44.87m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 27, 2025
Earnings per share (EPS) | 0.67 |
Gross Margin | 11.54% |
Net Profit Margin | 2.44% |
Debt/Equity Ratio | 10.9% |
How did RHKJ.F perform over the long term?
See historical performance and comparison